127 related articles for article (PubMed ID: 27054115)
1. CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line.
Rajabi Fomeshi M; Ebrahimi M; Mowla SJ; Firouzi J; Khosravani P
Cell J; 2016; 18(1):21-7. PubMed ID: 27054115
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
[TBL] [Abstract][Full Text] [Related]
3. Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells.
Roudi R; Ebrahimi M; Sabet MN; Najafi A; Nourani MR; Fomeshi MR; Samadikuchaksaraei A; Shariftabrizi A; Madjd Z
Future Oncol; 2015; 11(17):2383-93. PubMed ID: 26285774
[TBL] [Abstract][Full Text] [Related]
4. Functional features of cancer stem cells in melanoma cell lines.
Zimmerer RM; Korn P; Demougin P; Kampmann A; Kokemüller H; Eckardt AM; Gellrich NC; Tavassol F
Cancer Cell Int; 2013 Aug; 13(1):78. PubMed ID: 23915418
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
6. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling Warburg effect and stemness in CD133
Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
[TBL] [Abstract][Full Text] [Related]
8. Significantly increased expression of OCT4 and ABCG2 in spheroid body-forming cells of the human gastric cancer MKN-45 cell line.
Liu J; Wang L; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R
Oncol Lett; 2013 Oct; 6(4):891-896. PubMed ID: 24137432
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
10. CD133 Antigen as a Potential Marker of Melanoma Stem Cells:
Kloskowski T; Jarząbkowska J; Jundziłł A; Balcerczyk D; Buhl M; Szeliski K; Bodnar M; Marszałek A; Drewa G; Drewa T; Pokrywczyńska M
Stem Cells Int; 2020; 2020():8810476. PubMed ID: 33424978
[TBL] [Abstract][Full Text] [Related]
11. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.
Argaw-Denboba A; Balestrieri E; Serafino A; Cipriani C; Bucci I; Sorrentino R; Sciamanna I; Gambacurta A; Sinibaldi-Vallebona P; Matteucci C
J Exp Clin Cancer Res; 2017 Jan; 36(1):20. PubMed ID: 28125999
[TBL] [Abstract][Full Text] [Related]
12. [Effects of down-regulation of IGF2 gene on the biological characteristics of HCT116 colon cancer stem cells].
Zhao X; Li J; Liu HQ; Liu XL
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):580-586. PubMed ID: 31434448
[No Abstract] [Full Text] [Related]
13. c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells.
Zhang HL; Wang P; Lu MZ; Zhang SD; Zheng L
Oncol Lett; 2019 May; 17(5):4487-4493. PubMed ID: 30944638
[TBL] [Abstract][Full Text] [Related]
14. Oxytetracycline have the therapeutic efficiency in CD133
Song Y; Kim IK; Choi I; Kim SH; Seo HR
Sci Rep; 2018 Oct; 8(1):16100. PubMed ID: 30382122
[TBL] [Abstract][Full Text] [Related]
15. Selective enrichment of CD133
Lv K; Chen Z; Zhang X; Zhang Q; Liu L
Oncol Lett; 2018 Oct; 16(4):4567-4576. PubMed ID: 30197675
[TBL] [Abstract][Full Text] [Related]
16. Culturing in serum-free culture medium on collagen type-I-coated plate increases expression of CD133 and retains original phenotype of HT-29 cancer stem cell.
Arab-Bafrani Z; Shahbazi-Gahrouei D; Abbasian M; Saberi A; Fesharaki M; Hejazi SH; Manshaee S
Adv Biomed Res; 2016; 5():59. PubMed ID: 27135028
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
Sabet MN; Rakhshan A; Erfani E; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD133 in SW620 colorectal cancer cells is modulated by the microenvironment.
Yang Z; Wang Z; Fan Y; Zheng Q
Oncol Lett; 2012 Jul; 4(1):75-79. PubMed ID: 22807964
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
[TBL] [Abstract][Full Text] [Related]
20. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells.
Chen J; Zhao J; Ding J; Wang Z; Du J; Wu C
Braz J Med Biol Res; 2020; 53(7):e9230. PubMed ID: 32520208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
